Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Rivaroxaban with or without aspirin for prevention of cardiovascular disease

Kruger, Paul C.; Eikelboom, John W.; Yusuf, Salim

doi: 10.1097/MCA.0000000000000605
Viewpoint

Department of Medicine, Division of Hematology and Thromboembolism, Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada

Correspondence to Paul C. Kruger, MBBS, Population Health Research Institute, McMaster University and Hamilton Health Sciences, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton General Hospital, 237 Barton St East, Hamilton L8L 2X2, Canada Tel: +1 905 923 0285; fax: +1 905 521 1551; e-mail: paul.kruger@phri.ca

Received December 29, 2017

Accepted January 1, 2018

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.